Phase 2 respiratory biotech developing an antibody that targets the TSLP receptor.
Industry: Health Care
Latest Trade: $17.80 0.00 (0.0%)
First Day Return: +29.4%
Return from IPO: +4.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/18/2024 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 15.0 |
Deal Size ($mm) | $255 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/10/2024 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 15.0 |
Deal Size ($mm) | $255 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
TD Cowen |
more |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2021 |
Employees at IPO | 38 |
Website www.upstreambio.com |